Genetic Susceptibility to Nonsteroidal Anti-Inflammatory Drug–Related Gastroduodenal Bleeding: Role of Cytochrome P450 2C9 Polymorphisms
- 1 August 2007
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 133 (2), 465-471
- https://doi.org/10.1053/j.gastro.2007.05.025
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Simple and Effective Determination of Apolipoprotein E Genotypes by Positive/Negative Polymerase Chain Reaction ProductsDiagnostic Molecular Pathology, 2006
- IMPACT OFCYP2C9GENOTYPE ON PHARMACOKINETICS: ARE ALL CYCLOOXYGENASE INHIBITORS THE SAME?: TABLE 1Drug Metabolism and Disposition, 2005
- Upper gastrointestinal symptoms and therapies in elderly out‐patients, users of non‐selective NSAIDs or coxibsAlimentary Pharmacology & Therapeutics, 2005
- Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotypeBritish Journal of Clinical Pharmacology, 2004
- Genetic predisposition to acute gastrointestinal bleeding after NSAIDs useBritish Journal of Pharmacology, 2004
- Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolitesPharmacogenetics, 2003
- An approach toHelicobacter pyloriinfection in the elderlyAlimentary Pharmacology & Therapeutics, 2002
- Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African populationBritish Journal of Clinical Pharmacology, 2001
- Genetic analysis of the human cytochrome P450 CYP2C9 locusPharmacogenetics, 1996
- Bleeding Peptic UlcerThe New England Journal of Medicine, 1994